Analysis of complex protein mixtures with improved sequence coverage using (CE-MS/MS)n

被引:41
作者
Garza, Selynda [1 ]
Moini, Mehdi [1 ]
机构
[1] Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA
关键词
D O I
10.1021/ac0612269
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Identification of proteins, in a complex protein mixture, using one-dimensional high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) analysis of its digest, usually suffers from low sequence coverage. There are several reasons for the low coverage including undersampling, wide concentration dynamic range of the proteins in a complex protein mixture, and wide range of electrospray ionization efficiency of peptides under each mobile-phase composition. To address this low sequence coverage, we introduce a novel technique, (CE-MS/MS)(n), which utilizes the most significant advantages of CE-MS/MS, including economy of sample size, fast analysis time, and high separation efficiency, to increase the sequence coverage of a complex protein mixture. Based on these characteristics, (CE-MS/MS)(n) can be performed in which multiple CE-MS/MS subanalyses (injections followed by analyses) are analyzed and experimental variables are manipulated during each CE-MS/MS subanalysis in order to maximize sequence coverage. (CE-MS/MS)(n) is a practical technique since each CE-MS/MS subanalysis consumes <10 nL, and each CE-MS/MS subanalysis takes similar to 10 min; therefore, several subanalyses can be performed in similar to 1 h consuming only nanoliters of the sample. Two techniques have been introduced to address the undersampling: (1) (CE-MS/MS)(n) using dynamic exclusion. In this technique, several CE-MS/MS analyses (injection followed by separation) were performed in one run using the dynamic exclusion capability of the mass spectrometer until all peptide peaks were analyzed by MS/MS. (2) Gas-phase fractionation. In this technique, (CE-MS/MS)(n) is performed by scanning a narrow mass range (every similar to 100 m/z) during each CE-MS/MS subanalysis without using dynamic exclusion. Under this condition, in each subanalysis, the number of peptides available for MS/MS analysis is significantly reduced, and peptides with the same nominal masses are analyzed, thereby increasing sequence coverage. Additionally, to address the lack of detection of low-level peptides in a mixture containing a wide concentration dynamic range, the concentration of the sample was systematically increased in each subanalysis (while utilizing dynamic exclusion) so that low-intensity peptides would rise above the mass spectrometer threshold and, consequently, undergo MS/MS analysis. Moreover, to alter the ionization efficiency of peptides with low electrospray ionization efficiency, and to change the migration behavior of comigrating peptides under a specific liquid composition, the CE background electrolyte was modified in several subanalyses to further improve sequence coverage. The combination of the above-mentioned techniques was applied to the analysis of the tryptic digests of three well-characterized protein mixtures: a six-protein mixture with average MW of similar to 26 000 (standard I), a six-protein mixture with an average MW similar to 49 000 (standard II), and a more complex protein mixture containing 55 proteins (E. coli ribosomal proteins). In similar to 1 h, when the MS/MS of the peptides were manually checked, all peptides that produced peaks under electrospray ionization in the scanned range of the analysis (500-2000 m/z) and within the practical fragmentation capability of the MS (peptides with MW <3500) were identified for standard I by consuming only 200 fmol of each protein. When searched against a Swissprot database, the average sequence coverage for the standard I, II, and E. coli's ribosomal proteins were 57, 34, and 15%, respctively.
引用
收藏
页码:7309 / 7316
页数:8
相关论文
共 50 条
  • [31] Analysis of acid dye degradation products by CE-MS and HPLC
    Lu, Yiping
    Hardin, Ian R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1573 - U1573
  • [32] CE-MS and GC-MS as “Green” and Complementary Methods for the Analysis of Biogenic Amines in Wine
    Michał Woźniakiewicz
    Aneta Woźniakiewicz
    Paweł Mateusz Nowak
    Ewa Kłodzińska
    Jacek Namieśnik
    Justyna Płotka-Wasylka
    Food Analytical Methods, 2018, 11 : 2614 - 2627
  • [33] Analysis of orange II degradation products by GC-MS CE-MS, and HPLC.
    Lu, YP
    Zhao, XH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U102 - U102
  • [34] Quantification of main phenolic compounds in sweet and bitter orange peel using CE-MS/MS
    Sawalha, Saleh M. S.
    Arraez-Roman, David
    Segura-Carretero, Antonio
    Fernandez-Gutierrez, Alberto
    FOOD CHEMISTRY, 2009, 116 (02) : 567 - 574
  • [35] CE-MS and GC-MS as "Green" and Complementary Methods for the Analysis of Biogenic Amines in Wine
    Wozniakiewicz, Michal
    Wozniakiewicz, Aneta
    Nowak, Pawel Mateusz
    Klodzinska, Ewa
    Namiesnik, Jacek
    Plotka-Wasylka, Justyna
    FOOD ANALYTICAL METHODS, 2018, 11 (09) : 2614 - 2627
  • [36] Analysis of areca alkaloids and their conversions using CE-C4D and identification by CE-MS
    Huang, Jinying
    Ran, Jiaying
    Xia, Jingtong
    Du, Hongying
    Zhou, Lei
    FOOD CHEMISTRY, 2025, 483
  • [37] HPLC-MS and CE-MS with atmospheric pressure ionization in analysis of morphine and related compounds
    Smetková, M
    Ondra, P
    Lemr, K
    CHEMICKE LISTY, 2004, 98 (06): : 336 - 342
  • [38] The application of CE-MS in the trace analysis of environmental pollutants and food contaminants
    Rodriguez Robledo, Virginia
    Smyth, William Franklin
    ELECTROPHORESIS, 2009, 30 (10) : 1647 - 1660
  • [39] The analysis of basic and acidic compounds using non-aqueous CE and non-aqueous CE-MS
    Senior, J
    Rolland, D
    Tolson, D
    Chantzis, S
    De Biasi, V
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (03) : 413 - 421
  • [40] Rapid and comprehensive monoclonal antibody Characterization using microfluidic CE-MS
    Cao, Li
    Fabry, Daniel
    Lan, Kevin
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 204